Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosomes for Parkinson's Disease

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This trial will study the safety and efficacy of intranasal instillation of cultured allogeneic adult umbilical cord derived mesenchymal stem cell exosomes for the treatment of Parkinson's Disease
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-11-29; most recent amendment 2025-04-15.
Status change: Not Yet Recruiting → Recruiting 2025-04-15
Status change: Recruiting → Not Yet Recruiting 2022-01-27
Trial Details
NCT Number NCT05152394
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Parkinson Disease
Enrollment 20 participants
Start Date 2024-08-17
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-17